Theravance Biopharma, Inc. (TBPH) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 417.63M | 418.46M | 354.7M | 366.29M | 150.26M | 161.07M | 116.48M | 119.31M | 124.29M | 133.54M | 161.69M | 192M | 261.34M | 353.46M | 511.72M | 154.73M | 204.64M | 249.87M | 297.17M | 333.18M |
| Cash & Short-Term Investments | 394.67M | 315.36M | 329.68M | 338.8M | 130.85M | 88.35M | 91.36M | 96.08M | 99.97M | 102.43M | 134M | 167.45M | 241.26M | 327.48M | 486.83M | 132.85M | 147.52M | 173.47M | 216.21M | 264.95M |
| Cash Only | 288.1M | 167.81M | 174.77M | 281.93M | 110.61M | 37.8M | 23.38M | 46.34M | 53.84M | 39.55M | 71.69M | 105.6M | 187.66M | 298.17M | 418.54M | 87.29M | 94.37M | 89.96M | 121.42M | 204.95M |
| Short-Term Investments | 106.56M | 147.55M | 154.91M | 56.88M | 20.24M | 50.55M | 67.98M | 49.73M | 46.14M | 62.88M | 62.32M | 61.85M | 53.6M | 29.31M | 68.29M | 45.56M | 53.15M | 83.51M | 94.79M | 60M |
| Accounts Receivable | 15.58M | 95.54M | 18.27M | 21.92M | 15.35M | 68.44M | 16.84M | 14.3M | 14.66M | 17.47M | 17.06M | 15.8M | 12.27M | 16.79M | 14.11M | 12.49M | 12.28M | 57.6M | 14M | 39.96M |
| Days Sales Outstanding | 282.53 | 114.08 | 92.47 | 64.74 | 245.04 | 209.19 | 84.93 | 92.44 | 100.83 | 90.43 | 96.3 | 92.88 | 125.51 | 97.03 | 98.28 | 101.97 | 238.29 | 220.37 | 188.13 | 182.78 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 7.38M | 7.56M | 6.75M | 5.57M | 4.06M | 4.2M | 7.68M | 6.28M | 7.57M | 11.6M | 9M | 7.78M | 6.28M | 7.68M | 8.13M | 7.08M | 35.56M | 8.56M | 43.77M | 12.35M |
| Total Non-Current Assets | 54.68M | 67.11M | 60.76M | 59.74M | 193.32M | 193.09M | 239.63M | 242.72M | 247.01M | 248.46M | 251.9M | 254.63M | 277.21M | 253.94M | 251.78M | 206.03M | 150.72M | 124.95M | 105.94M | 96.07M |
| Property, Plant & Equipment | 28.54M | 30.27M | 31.71M | 33.13M | 34.46M | 35.77M | 37.12M | 39.96M | 44.08M | 45.35M | 46.86M | 48.01M | 51.31M | 52M | 51.88M | 53.64M | 52.59M | 53.35M | 56.72M | 58.09M |
| Fixed Asset Turnover | 0.60x | 1.48x | 0.62x | 0.78x | 0.44x | 0.51x | 0.44x | 0.34x | 0.32x | 0.38x | 0.33x | 0.28x | 0.20x | 0.28x | 0.24x | 0.21x | 0.25x | 0.27x | 0.23x | 0.22x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 836K | 14.35M | 3.03M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.78M | 0 | 0 | 149.09M | 94.11M | 68.37M | 45.09M | 36.66M |
| Other Non-Current Assets | 25.3M | 22.5M | 26.03M | 26.61M | 158.86M | 157.32M | 202.5M | 202.76M | 202.93M | 203.1M | 205.04M | 206.62M | 207.13M | 201.94M | 199.9M | 3.3M | 4.03M | 3.23M | 4.13M | 1.32M |
| Total Assets | 472.31M | 485.57M | 415.46M | 426.04M | 343.58M | 354.16M | 356.11M | 362.03M | 371.31M | 382M | 413.59M | 446.63M | 538.55M | 607.4M | 763.5M | 360.76M | 355.36M | 374.82M | 403.11M | 429.25M |
| Asset Turnover | 0.04x | 0.10x | 0.05x | 0.07x | 0.04x | 0.05x | 0.05x | 0.04x | 0.04x | 0.04x | 0.04x | 0.03x | 0.02x | 0.02x | 0.02x | 0.03x | 0.04x | 0.04x | 0.03x | 0.03x |
| Asset Growth % | 37.47% | 37.1% | 16.67% | 17.68% | -7.47% | -7.29% | -13.9% | -18.94% | -31.05% | -37.11% | -45.83% | 23.8% | 51.55% | 62.05% | 89.4% | -15.96% | -5.26% | -20.09% | -21.3% | -23.94% |
| Total Current Liabilities | 31.77M | 38.3M | 37.41M | 54.63M | 31.5M | 32.09M | 23.43M | 22.95M | 21.66M | 24.77M | 25.37M | 24.55M | 26.18M | 28.71M | 142.13M | 32.62M | 44.2M | 58.59M | 66.08M | 67.13M |
| Accounts Payable | 1.1M | 2.57M | 2.21M | 1.68M | 2.41M | 2.24M | 1.45M | 1.67M | 1.69M | 1.52M | 2.37M | 1.57M | 2.66M | 1.55M | 5.34M | 3.07M | 1.51M | 3.1M | 8.9M | 10.7M |
| Days Payables Outstanding | 114.86 | 146.03 | 22.05 | 17.71 | 18.27 | - | 15.53 | 15.36 | 16.29 | 21.54 | 135.25 | 20.43 | 13.02 | 20.65 | 39.21 | 13.98 | 8.92 | 17.67 | 20.62 | 15.62 |
| Short-Term Debt | 10.75M | 10.95M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.62M | 9.01M | 17.44M | 12.53M | 7.98M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24K | 24K | 24K | 24K | 24K | 24K | 0 | 98K | 0 | 5.69M |
| Other Current Liabilities | 14.64M | 19.5M | 0 | 0 | 0 | 0 | 6.49M | 0 | 0 | 0 | 0 | 0 | 0 | -24K | 120.55M | 19.94M | 98K | 25.15M | 2.9M | 28.12M |
| Current Ratio | 13.14x | 10.93x | 9.48x | 6.70x | 4.77x | 5.02x | 4.97x | 5.20x | 5.74x | 5.39x | 6.37x | 7.82x | 9.98x | 12.31x | 3.60x | 4.74x | 4.63x | 4.26x | 4.50x | 4.96x |
| Quick Ratio | 13.14x | 10.93x | 9.48x | 6.70x | 4.77x | 5.02x | 4.97x | 5.20x | 5.74x | 5.39x | 6.37x | 7.82x | 9.98x | 12.31x | 3.60x | 4.74x | 4.63x | 4.26x | 4.50x | 4.96x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 149.94M | 150.54M | 145.37M | 146.55M | 146.1M | 146.53M | 147.02M | 145.39M | 144.78M | 144.24M | 142.09M | 141.92M | 141.81M | 136.88M | 140.79M | 677.95M | 662.61M | 654.8M | 660.62M | 662.5M |
| Long-Term Debt | 32.8M | 32.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 624.7M | 612.46M | 599.39M | 603.34M | 602.57M |
| Capital Lease Obligations | 29.75M | 31.76M | 33.68M | 35.56M | 37.35M | 39.11M | 40.78M | 42.44M | 43.84M | 45.24M | 41.12M | 42.52M | 43.76M | 45.41M | 51.38M | 50.64M | 47.41M | 52.68M | 54.35M | 57.77M |
| Deferred Tax Liabilities | 87.15M | 85.68M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 240K | 0 | 0 |
| Other Non-Current Liabilities | 244K | 313K | 111.69M | 110.99M | 108.75M | 107.42M | 106.23M | 102.95M | 100.94M | 99M | 100.8M | 99.22M | 97.86M | 91.29M | 89.21M | 2.4M | 2.73M | 2.18M | 2.93M | 1.83M |
| Total Liabilities | 181.72M | 188.85M | 182.78M | 201.19M | 177.6M | 178.62M | 170.45M | 168.34M | 166.44M | 169M | 167.46M | 166.47M | 167.99M | 165.6M | 282.92M | 710.57M | 706.81M | 713.39M | 726.7M | 729.63M |
| Total Debt | 73.3M | 75.5M | 44.59M | 46.46M | 48.16M | 49.82M | 44.98M | 46.66M | 47.9M | 49.16M | 50.83M | 51.68M | 51.19M | 52.16M | 52.07M | 677.96M | 672.95M | 669.52M | 671.24M | 668.31M |
| Net Debt | -214.8M | -92.31M | -130.18M | -235.47M | -62.46M | 12.02M | 21.6M | 315K | -5.93M | 9.61M | -20.85M | -53.91M | -136.47M | -246.01M | -366.46M | 590.67M | 578.58M | 579.56M | 549.81M | 463.37M |
| Debt / Equity | 0.25x | 0.25x | 0.19x | 0.21x | 0.29x | 0.28x | 0.24x | 0.24x | 0.23x | 0.23x | 0.21x | 0.18x | 0.14x | 0.12x | 0.11x | - | - | - | - | - |
| Debt / EBITDA | - | 3.96x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | -4.84x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | 30.13x | -4.04x | -4.11x | -22.45x | -12.90x | -14.72x | -19.80x | -17.82x | -10.59x | -11.45x | -26.33x | -42.43x | -31.64x | -8.86x | -9.40x | -13.06x | -3.24x | -24.27x | -5.52x |
| Total Equity | 290.59M | 296.72M | 232.68M | 224.85M | 165.98M | 175.54M | 185.65M | 193.69M | 204.87M | 213M | 246.13M | 280.16M | 370.56M | 441.8M | 480.58M | -349.81M | -351.45M | -338.57M | -323.59M | -300.37M |
| Equity Growth % | 75.07% | 69.03% | 25.33% | 16.09% | -18.98% | -17.58% | -24.57% | -30.87% | -44.71% | -51.79% | -48.78% | 180.09% | 205.44% | 230.49% | 248.51% | -16.46% | 5.83% | -11.46% | -23.73% | -48.45% |
| Book Value per Share | 5.67 | 5.59 | 4.48 | 4.43 | 3.34 | 3.56 | 3.79 | 3.97 | 4.24 | 4.31 | 4.70 | 4.94 | 5.89 | 6.56 | 6.36 | -4.59 | -4.67 | -4.58 | -4.40 | -4.57 |
| Total Shareholders' Equity | 290.59M | 296.72M | 232.68M | 224.85M | 165.98M | 175.54M | 185.65M | 193.69M | 204.87M | 213M | 246.13M | 280.16M | 370.56M | 441.8M | 480.58M | -349.81M | -351.45M | -338.57M | -323.59M | -300.37M |
| Common Stock | 1K | 1K | 1K | 1K | 1K | 0 | 0 | 0 | 0 | 0 | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K |
| Retained Earnings | -864.56M | -859.63M | -920.65M | -924.27M | -979.1M | -965.52M | -950M | -937.3M | -920.77M | -909.1M | -900.59M | -891.64M | -876M | -853.91M | -843.55M | -1.76B | -1.75B | -1.73B | -1.69B | -1.66B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -62K | 61K | 32K | -10K | 0 | 7K | 50K | -22K | -41K | -65K | -225K | -286K | 51K | -15K | -121K | -45K | -28K | 0 | 14K | 8K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |